EXTX — Exact Therapeutics AS Share Price
0.000.00%
Last trade - 00:00- NOK179.98m
- NOK142.30m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4 | ||
| Price to Tang. Book | 4 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -79.8% | ||
| Return on Equity | -58.6% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | NOKm | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Exact Therapeutics AS is a Norway-based clinical-stage biopharmaceutical company, which develops ultrasound-mediated technology platform for targeted therapeutic enhancement Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The Company's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. It is done through harnessing the power of ultrasound in combination with ACT formulation.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- April 30th, 2012
- Public Since
- July 14th, 2020
- No. of Employees
- 8
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Oslo Stock Exchange
- Shares in Issue
- 29,997,219
- Address
- Ostre Aker vei 19, OSLO, 0581
- Web
- https://www.exact-tx.com/
- Phone
- Auditors
- Ernst & Young AS
Upcoming Events for EXTX
Similar to EXTX
Arcticzymes Technologies ASA
Oslo Stock Exchange
Bergenbio ASA
Oslo Stock Exchange
Circio Holding ASA
Oslo Stock Exchange
Lifecare AS
Oslo Stock Exchange
Lytix Biopharma AS
Oslo Stock Exchange
FAQ
What is the Exact Therapeutics AS share price?
As of Today at 19:08 UTC, shares in Exact Therapeutics AS are trading at NOK6.00. This share price information is delayed by 15 minutes.
How has the Exact Therapeutics AS share price performed this year?
Shares in Exact Therapeutics AS last closed at NOK6.00 and the price had moved by -58.62% over the past 365 days. In terms of relative price strength the Exact Therapeutics AS share price has underperformed the FTSE Global All Cap Index by -61.83% over the past year.
What are the analyst and broker recommendations for Exact Therapeutics AS?
There is no consensus recommendation for this security.
What is the Exact Therapeutics AS dividend yield?
Exact Therapeutics AS does not currently pay a dividend.
Does Exact Therapeutics AS pay a dividend?
Exact Therapeutics AS does not currently pay a dividend.
When does Exact Therapeutics AS next pay dividends?
Exact Therapeutics AS does not currently pay a dividend.
How do I buy Exact Therapeutics AS shares?
To buy shares in Exact Therapeutics AS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Exact Therapeutics AS?
As of the previous close price of NOK6.00, shares in Exact Therapeutics AS had a market capitalisation of NOK179.98m.
Where are Exact Therapeutics AS shares listed?
Here are the trading details for Exact Therapeutics AS:
- Country of listing: Norway
- Exchange: OSL
- Ticker Symbol: EXTX
What kind of share is Exact Therapeutics AS?
Based on an overall assessment of its quality, value and momentum Exact Therapeutics AS is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Exact Therapeutics AS share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Exact Therapeutics AS share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Exact Therapeutics AS. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -66.5%.
As of the last closing price of NOK6.00, shares in Exact Therapeutics AS were trading -58.32% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Exact Therapeutics AS PE Ratio?
The Exact Therapeutics AS PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at NOK6.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Exact Therapeutics AS?
We do not have data on Exact Therapeutics AS' directors